1-3 of 3
Andrew W. Hahn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer

Umang Swami, Nicolas Sayegh, Yeonjung Jo, Benjamin Haaland, Taylor Ryan McFarland, Roberto H. Nussenzveig, Divyam Goel, Deepika Sirohi, Andrew W. Hahn, Benjamin L. Maughan, Amir Goldkorn, Neeraj Agarwal
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1857–1861.
https://doi.org/10.1158/1535-7163.MCT-22-0020
Published: 02 December 2022
View article titled, External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer
Open the PDF for External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract P041: Initial results from a phase 1b study of ORIC-101, a glucocorticoid receptor antagonist, in combination with enzalutamide in patients with metastatic prostate cancer

Wassim Abida, Neeraj Agarwal, Andrew W. Hahn, Neal Shore, Paul Sieber, Tanya Dorff, Mathew Rettig, Mathew Smith, Paul Monk, Rongda Xu, Ann Johnson, Anneleen Daemen, Edna Chow Maneval, Pratik S. Multani, Rupal Patel, Michael J. Morris
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P041.
https://doi.org/10.1158/1535-7163.TARG-21-P041
Published: 01 December 2021
View article titled, Abstract P041: Initial results from a phase 1b study of ORIC-101, a glucocorticoid receptor antagonist, in combination with enzalutamide in patients with metastatic prostate cancer
Journal Articles

Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC)

Andrew W. Hahn, David M. Gill, Austin Poole, Roberto H. Nussenzveig, Sara Wilson, James M. Farnham, Robert A. Stephenson, Lisa A. Cannon-Albright, Benjamin L. Maughan, Neeraj Agarwal
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 726–729.
https://doi.org/10.1158/1535-7163.MCT-18-0739
Published: 01 March 2019
View article titled, Germline Variant in <em>SLCO2B1</em> and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC)
Open the PDF for Germline Variant in <em>SLCO2B1</em> and Response to Abiraterone Acetate Plus Prednisone (AA) in New-onset Metastatic Castration-resistant Prostate Cancer (mCRPC) in another window